Clarification: Assessing baseline coagulation status under NPSG.03.05.01.
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007591:Joint Commission on Accreditation of Healthcare Organizations; D017751:Safety Management / Q000592:standards*; D014481:United States
D000925:Anticoagulants